Slideshow

Neuro News Roundup: Parkinson or parkinsonian?

Author(s):

Studies also include stem cell transplantation for treatment-refractory MS and aspirin use for headache to lessen the need for rescue medication.

The highlights of new studies in neurology include: a single dose of aspirin, from 500 mg to 1000 mg, may reduce the use of rescue medications in adults with frequent episodic tension-type headache; blood neurofilament light chain (NfL) protein can discriminate between Parkinson disease and atypical parkinsonian disorder; and about half of patients with aggressive, treatment-refractory multiple sclerosis (MS) are free from neurological progression five years after autologous hematopoietic stem cell transplantation (AHSCT).

Related Videos
Kathleen Costello, CRNP, MSCN
Christian Cordano, MD, PhD
Jack P. Antel, M D
Sarah Levy, PhD
Enrique Alvarez, MD, PhD
Ceren Tozlu, PhD
Cristin Welle, PhD
Patricia K. Coyle, MD
© 2025 MJH Life Sciences

All rights reserved.